G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 115 filers reported holding G1 THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $22,000 | +144.4% | 1,750 | 0.0% | 0.03% | +163.6% |
| Q2 2022 | $9,000 | -47.1% | 1,750 | -22.2% | 0.01% | -42.1% |
| Q1 2022 | $17,000 | -29.2% | 2,250 | -4.3% | 0.02% | -29.6% |
| Q4 2021 | $24,000 | -38.5% | 2,350 | -19.7% | 0.03% | -42.6% |
| Q3 2021 | $39,000 | -39.1% | 2,925 | 0.0% | 0.05% | -41.2% |
| Q2 2021 | $64,000 | -8.6% | 2,925 | 0.0% | 0.08% | -20.0% |
| Q1 2021 | $70,000 | +32.1% | 2,925 | 0.0% | 0.10% | +13.6% |
| Q4 2020 | $53,000 | +55.9% | 2,925 | 0.0% | 0.09% | +35.4% |
| Q3 2020 | $34,000 | -52.1% | 2,925 | 0.0% | 0.06% | -63.3% |
| Q2 2020 | $71,000 | +184.0% | 2,925 | +30.0% | 0.18% | +152.9% |
| Q1 2020 | $25,000 | – | 2,250 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
| Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
| Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
| 361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
| CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
| Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
| Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
| Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
| HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |